INC Research Holdings, Inc. (NASDAQ:INCR) shot up 5.6% during trading on Thursday . The stock traded as high as $38.10 and last traded at $38.00. 2,295,460 shares changed hands during trading, an increase of 154% from the average session volume of 905,274 shares. The stock had previously closed at $36.00.

Several research firms recently commented on INCR. TheStreet raised INC Research Holdings from a “c” rating to a “b-” rating in a research report on Monday, November 6th. BidaskClub cut INC Research Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Jefferies Group LLC reaffirmed a “hold” rating and set a $62.50 price objective on shares of INC Research Holdings in a research report on Sunday, July 30th. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and set a $65.00 price objective on shares of INC Research Holdings in a research report on Monday, August 7th. Finally, Credit Suisse Group began coverage on INC Research Holdings in a research report on Wednesday, October 11th. They set an “outperform” rating and a $68.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $56.33.

The company has a market cap of $3,970.00 and a PE ratio of 15.76. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.99.

INC Research Holdings (NASDAQ:INCR) last announced its earnings results on Thursday, November 9th. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by ($0.09). The firm had revenue of $592.21 million during the quarter, compared to analysts’ expectations of $604.95 million. INC Research Holdings had a positive return on equity of 14.42% and a negative net margin of 4.29%. The company’s revenue for the quarter was up 128.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.64 earnings per share. analysts forecast that INC Research Holdings, Inc. will post 2.29 EPS for the current fiscal year.

In other news, CFO Gregory S. Rush sold 41,420 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $58.26, for a total value of $2,413,129.20. Following the transaction, the chief financial officer now owns 42,793 shares of the company’s stock, valued at $2,493,120.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Gregory S. Rush sold 9,703 shares of the firm’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $54.48, for a total value of $528,619.44. Following the completion of the transaction, the chief financial officer now directly owns 78,593 shares in the company, valued at approximately $4,281,746.64. The disclosure for this sale can be found here. Insiders sold 189,493 shares of company stock worth $11,059,514 over the last three months. Insiders own 0.24% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of INCR. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of INC Research Holdings by 14.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after buying an additional 228 shares during the period. Pacad Investment Ltd. bought a new position in shares of INC Research Holdings in the second quarter worth about $123,000. Riverhead Capital Management LLC bought a new position in shares of INC Research Holdings in the second quarter worth about $128,000. Victory Capital Management Inc. raised its stake in shares of INC Research Holdings by 17.6% in the second quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after buying an additional 356 shares during the period. Finally, Personal Capital Advisors Corp bought a new position in shares of INC Research Holdings in the third quarter worth about $234,000. 77.75% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This report was originally published by Daily Political and is the property of of Daily Political. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.dailypolitical.com/2017/11/16/inc-research-holdings-inc-incr-shares-up-5-6.html.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.